A Human Factor Study To Asses The Usability And Feasibility Of The Peritron+ During Intended Use
Study Details
Study Description
Brief Summary
In a hospital setting, the self-measurement of intravesical pressure (SMIP) assessment will be conducted at full and empty bladder using the Peritron+ and a ruler-based manometry method. In the home setting a human factor/usability study will be conducted to measure the subject's ability to perform a successful SMIP assessment at full and empty bladder with the Peritron+. This study involves the use of the Peritron+, Air-Trap Tubing, a ruler and a clean intermittent catheter (CIC).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Peritron+ SMIP assessment using Peritron+, Air-Trap Tubing, and a conventional CIC catheter |
Device: Peritron+
Peritron+ device to measure intravesical pressure
|
Outcome Measures
Primary Outcome Measures
- Usability Factors; Simple, Doable, and is Comparable to the Ruler-based Manometry Method Using a Questionnaire and Patient Diary. [Through study completion, an average of 4 days]
Each participant could score between 0 and 39 and the total score range for group is 0 to 195. All questionnaires and patient diary questions were summed across the board for patients to derive a total score for the Arm/Group
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Children (2 to 18 years old)
-
Subjects who perform CIC regularly
-
Must be able to understand English instructions (written or oral)
Exclusion Criteria:
- Subjects suffering from symptomatic bladder infection
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Laborie Medical Technologies Inc.
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PLUS-HF-01
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Peritron+ |
---|---|
Arm/Group Description | SMIP assessment using Peritron+, Air-Trap Tubing, and a conventional CIC catheter Peritron+: Peritron+ device to measure intravesical pressure |
Period Title: Overall Study | |
STARTED | 5 |
COMPLETED | 5 |
NOT COMPLETED | 0 |
Baseline Characteristics
Arm/Group Title | Peritron+ |
---|---|
Arm/Group Description | SMIP assessment using Peritron+, Air-Trap Tubing, and a conventional CIC catheter Peritron+: Peritron+ device to measure intravesical pressure |
Overall Participants | 5 |
Age (Count of Participants) | |
<=18 years |
5
100%
|
Between 18 and 65 years |
0
0%
|
>=65 years |
0
0%
|
Gender (Count of Participants) | |
Female |
2
40%
|
Male |
3
60%
|
Region of Enrollment (participants) [Number] | |
United States |
5
100%
|
Outcome Measures
Title | Usability Factors; Simple, Doable, and is Comparable to the Ruler-based Manometry Method Using a Questionnaire and Patient Diary. |
---|---|
Description | Each participant could score between 0 and 39 and the total score range for group is 0 to 195. All questionnaires and patient diary questions were summed across the board for patients to derive a total score for the Arm/Group |
Time Frame | Through study completion, an average of 4 days |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Peritron+ |
---|---|
Arm/Group Description | SMIP assessment using Peritron+, Air-Trap Tubing, and a conventional CIC catheter Peritron+: Peritron+ device to measure intravesical pressure |
Measure Participants | 5 |
Number [participants] |
65
1300%
|
Adverse Events
Time Frame | ||
---|---|---|
Adverse Event Reporting Description | ||
Arm/Group Title | Peritron+ | |
Arm/Group Description | SMIP assessment using Peritron+, Air-Trap Tubing, and a conventional CIC catheter Peritron+: Peritron+ device to measure intravesical pressure | |
All Cause Mortality |
||
Peritron+ | ||
Affected / at Risk (%) | # Events | |
Total | / (NaN) | |
Serious Adverse Events |
||
Peritron+ | ||
Affected / at Risk (%) | # Events | |
Total | 0/5 (0%) | |
Other (Not Including Serious) Adverse Events |
||
Peritron+ | ||
Affected / at Risk (%) | # Events | |
Total | 0/5 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
Sponsor can review results communications prior to public release regarding trial results for a period that is less than 60 days. The sponsor can request changes to the communication.
Results Point of Contact
Name/Title | Clinical Researcher |
---|---|
Organization | Laborie |
Phone | 9056121170 ext 1755 |
sbitzos@laborie.com |
- PLUS-HF-01